PolyPeptide Group AG (0AAJ.L)

CHF 16.06

(3.48%)

Long Term Debt Summary of PolyPeptide Group AG

PolyPeptide Group AG's latest annual long term debt in 2023 was 67.95 Million EUR , up 622.17% from previous year.
PolyPeptide Group AG's latest quarterly long term debt in 2023 FY was 67.95 Million EUR , up 622.17% from previous quarter.
PolyPeptide Group AG reported annual long term debt of 9.41 Million EUR in 2022, down -8.66% from previous year.
PolyPeptide Group AG reported annual long term debt of 10.3 Million EUR in 2021, down -71.31% from previous year.
PolyPeptide Group AG reported quarterly long term debt of 67.95 Million EUR for 2023 FY, up 622.17% from previous quarter.
PolyPeptide Group AG reported quarterly long term debt of 67.95 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of PolyPeptide Group AG (2023 - 2018)

Historical Annual Long Term Debt of PolyPeptide Group AG (2023 - 2018)

Year	Long Term Debt	Long Term Debt Growth
2023	67.95 Million EUR	622.17%
2022	9.41 Million EUR	-8.66%
2021	10.3 Million EUR	-71.31%
2020	35.9 Million EUR	6.0%
2019	33.86 Million EUR	35.48%
2018	25 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q2	9.6 Million EUR	0.0%
2023 FY	67.95 Million EUR	622.17%
2023 Q4	67.95 Million EUR	0.0%
2022 Q4	9.41 Million EUR	0.0%
2022 Q2	10.03 Million EUR	0.0%
2022 FY	9.41 Million EUR	-8.66%
2021 Q4	10.3 Million EUR	0.0%
2021 Q2	10.8 Million EUR	0.0%
2021 FY	10.3 Million EUR	-71.31%
2020 FY	35.9 Million EUR	6.0%
2020 Q4	35.9 Million EUR	0.0%
2019 Q4	6.25 Million EUR	0.0%
2019 Q3	6.25 Million EUR	0.0%
2019 Q2	6.25 Million EUR	0.0%
2019 Q1	6.25 Million EUR	0.0%
2019 FY	33.86 Million EUR	35.48%
2018 Q2	6.25 Million EUR	0.0%
2018 Q4	6.25 Million EUR	0.0%
2018 Q3	6.25 Million EUR	0.0%
2018 FY	25 Million EUR	0.0%
2018 Q1	6.25 Million EUR	0.0%

Peer Long Term Debt Comparison of PolyPeptide Group AG

Name	Long Term Debt	Long Term Debt Difference
Kuros Biosciences AG	1.56 Million CHF	-4242.236%